Adage Capital Partners
INSY

Adage Capital Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

Adage Capital Partners’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-275,000
Closed -$3.56M – 746
2016
Q2 		$3.56M Sell
275,000
-125,000
-31% -$1.82M 0.01% 618
2016
Q1 		$6.4M Buy
400,000
+135,000
+51% +$2.56M 0.02% 582
2015
Q4 		$7.59M Buy
+265,000
New +$7.34M 0.02% 562
2015
Q2 		– Sell
-550,000
Closed -$16M – 781
2015
Q1 		$16M Sell
550,000
-13,124
-2% -$347K 0.04% 464
2014
Q4 		$11.9M Buy
563,124
+460,510
+449% +$9.11M 0.03% 515
2014
Q3 		$1.99M Buy
+102,614
New +$1.61M ﹤0.01% 673

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adage Capital Partners's INSY Position: Q3 2016 in Review

Adage Capital Partners sold out of Insys Therapeutics, Inc. (INSY) in Q3 2016, closing a stake of 275,000 shares — an estimated $3.56M sold.

Adage Capital Partners first reported a position in INSY in Q3 2014 and held it in 6 quarters. The position peaked at $16M in Q1 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

  • Adage Capital Partners reported no remaining Insys Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Adage Capital Partners sold 275,000 Insys Therapeutics, Inc. shares in Q3 2016, an estimated $3.56M.
  • Adage Capital Partners first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 6 quarters.
  • Adage Capital Partners's Insys Therapeutics, Inc. position peaked at $16M in Q1 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.